Search

Your search keyword '"Bunnell, Craig A."' showing total 49 results

Search Constraints

Start Over You searched for: Author "Bunnell, Craig A." Remove constraint Author: "Bunnell, Craig A." Search Limiters Peer Reviewed Remove constraint Search Limiters: Peer Reviewed Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
49 results on '"Bunnell, Craig A."'

Search Results

1. Design and Implementation of an Opt-Out, End-to-End, Preemptive DPYD Testing Program for Patients Planned for a Systemic Fluoropyrimidine

2. Neuroinvasive Bacillus cereus Infection in Immunocompromised Hosts: Epidemiologic Investigation of 5 Patients With Acute Myeloid Leukemia

4. 1452. Neuroinvasive Bacillus Cereus Infection Amongst Immunocompromised Patients: Epidemiological Investigation of 5 Cases in Patients with Acute Myeloid Leukemia

9. Identifying Patterns and Barriers in OncotypeDX Recurrence Score Testing in Older Patients With Early-Stage, Estrogen Receptor–Positive Breast Cancer: Implications for Guidance and Reimbursement

13. Data-Driven Performance Analysis of Scheduled Processes

14. Discovery and Validation of Queueing Networks in Scheduled Processes

20. Early Findings on the Use of Clinical Pathways for Management of Unwarranted Variation in Cancer Care.

23. Outcomes of immunotherapy administration for hospitalized cancer patients.

26. Age and the Risk of Paclitaxel-Induced Neuropathy in Women with Early-Stage Breast Cancer (Alliance A151411): Results from 1,881 Patients from Cancer and Leukemia Group B (CALGB) 40101

28. Developing a Novel Model to Improve Research and care for Cancer Survivors: a Feasibility Study

29. Implementation of Surgeon-Initiated Gene Expression Profile Testing (Oncotype DX) Among Patients With Early-Stage Breast Cancer to Reduce Delays in Chemotherapy Initiation

33. Getting Ready for Engineered Cell Therapies—an Administrative Perspective

34. A Systematic Approach to Providing Safe Quality Care for Patients Receiving Engineered, Non-Stem Cell Therapies

37. Age and the Risk of Paclitaxel‐Induced Neuropathy in Women with Early‐Stage Breast Cancer (Alliance A151411): Results from 1,881 Patients from Cancer and Leukemia Group B (CALGB) 40101.

38. Impact of Genomic Assay Testing and Clinical Factors on Chemotherapy Use After Implementation of Standardized Testing Criteria.

41. Workload and Errors: Utilizing Data Collected Through Sensors in an Outpatient Cancer Facility.

42. Variation in the use of granulocyte-colony stimulating factor (G-CSF) for dose dense paclitaxel: A single institution retrospective study.

46. Standardizing coordination between surgical oncology and reconstructive surgery for breast cancer patients undergoing mastectomy with immediate reconstruction.

47. 113 - Getting Ready for Engineered Cell Therapies—an Administrative Perspective

49. Implementation of Surgeon-Initiated Gene Expression Profile Testing (Onco type DX) Among Patients With Early-Stage Breast Cancer to Reduce Delays in Chemotherapy Initiation.

Catalog

Books, media, physical & digital resources